concerns

Go to content
The COVID-19 pandemic led to an unprecedented global effort to develop and distribute vaccines. One of the most controversial technologies was mRNA vaccination. However, grave concerns have been raised since their roll-out, and were raised before rollout, regarding the danger of mRNA vaccines on the immune system, and other deadly side effects. Here are the facts...
Home and hybrid working models have gained significant traction recently due to the global pandemic. While many employees appreciate these arrangements' flexibility and work-life balance, companies often grapple with several concerns. Let's explore the reasons behind businesses' scepticism towards remote and hybrid work structures.
08 May 2024 - the European Medicines Agency (EMA) announced the withdrawal of the authorisation for AstraZeneca's Vaxzevria at the request of the marketing authorisation holder. The EMA had initially approved AstraZeneca's COVID-19 vaccine in January 2021. However, concerns about its safety arose when several countries suspended its use due to blood clots in vaccinated individuals.
Back to content